Press Releases
Press Release
Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart
April 14, 2020
Press Release
Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure
April 01, 2020
Press Release
Cardiol Therapeutics Announces Filing of 2019 Year-end Financial Statements and MD&A
March 26, 2020
Press Release
Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.
March 18, 2020
Press Release
Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation
March 05, 2020
Press Release
Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada
January 15, 2020
Press Release
Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor
December 18, 2019
Press Release
Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to its Board of Directors
December 03, 2019
Press Release
Cardiol Therapeutics comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency
November 25, 2019
